Floatz logo

Nelitolimod

Grade 1 Follicular Lymphoma

Ronald Levynucleic_acidPhase 1/2Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

210 Active assets in the Grade 1 Follicular Lymphoma cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2/3BBB
Romidepsin
City of Hope Medical Center
Phase 2BBB
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 3BBB
Recombinant Human Hyaluronidase
National Cancer Institute (NCI)
Phase 3BBB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BBB

View all 50 →

Same molecule, other indications

Nelitolimod is also rated in:

chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CCC
Indicative ·
54 / 100
View asset →
marginal zone lymphomaDormant
CCC
Indicative ·
52 / 100
View asset →
prostate neoplasmDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →